Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levobupivacaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Labor Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 20, 2024
Lead Product(s) : Levobupivacaine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hernia, Inguinal.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 31, 2022
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Ultrasound-guided Ilioinguinal/Iliohypogastric Nerve Block
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hernia, Inguinal.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 29, 2022
Lead Product(s) : Levobupivacaine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Fresenius Kabi AB Brunna
Deal Size : Inapplicable
Deal Type : Inapplicable
MORphine Use in the Fascia Iliaca Compartment Block With UltraSound
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 19, 2019
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Fresenius Kabi AB Brunna
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
LaGRA Trial in Laparoscopic Cholecystectomy
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gallstones.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 09, 2018
Lead Product(s) : Levobupivacaine
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Admescope
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy of Rectal Sheath Analgesia After Midline Laparotomy
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of General Surgery.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 17, 2016
Lead Product(s) : Levobupivacaine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Admescope
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III, Evaluate Noninferiority Between Levobupivacaine and Bupivacaine in Spinal Anesthesia.
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Spinal Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 26, 2013
Lead Product(s) : Levobupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Newco Trials Pesquisa Científica Ltda
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levobupivacaine
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Infusion of a Local Anaesthetic in the Surgical After Modified Radical Mastectomy With Expander
Details : Levobupivacaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2011
Lead Product(s) : Levobupivacaine
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable